Why the Xanax recall may not impact your prescription

(NEXSTAR) – The recall of a drug commonly used to treat anxiety and panic disorders may have you checking your medicine cabinet to see if you’re impacted.

Thankfully, there may not be much cause for alarm.

An updated notice from the U.S. Food and Drug Administration shows Viatris, Inc. issued a voluntary recall of a single lot ot extended-release Xanax XR, or alprazolam. The 3 mg prescription-only tablets, packaged in 60-tablet bottles, were distributed nationwide.

This lot didn’t meet dissolution specifications, health regulators said, meaning the tablets may not distribute the correct dosage over time or were otherwise not consistent.

Last week, the FDA classified the recall, originally issued in March, as Class II, meaning the impacted tablets could “cause temporary or........

© The Hill